Pharmaceuticals

Omega 3 Prescription Drugs Market 2026–2035 gaining traction with rising cardiovascular health awareness

March 23, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Omega 3 Prescription Drugs Market Expected To Change Between 2026 And 2030?

The omega 3 prescription drugs market size has experienced substantial growth in recent years. It is anticipated to increase from $1.75 billion in 2025 to $1.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. This historical expansion can be attributed to factors such as the high prevalence of hypertriglyceridemia, a growing awareness of cardiovascular diseases, an increasing geriatric population, the availability of prescription omega-3 drugs, and an expansion in clinical research and trials.

The omega 3 prescription drugs market size is projected to experience robust expansion over the coming years. It is anticipated to grow to $2.81 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.0%. The increase during the forecast period can be attributed to advancements in precision medicine, a rising demand for personalized therapies, the integration of digital health tools, an expansion into emerging markets, and innovation in omega-3 drug formulations. Significant trends expected in this period include the development of personalized omega-3 therapies, an increase in clinical trials for omega-3 formulations, a growth in cardiovascular risk management solutions, an expansion of prescription omega-3 drug accessibility, and enhanced nutraceutical-pharmaceutical integration.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8091&type=smp

Which Economic Or Industry Drivers Are Impacting The Omega 3 Prescription Drugs Market?

The increasing incidence of cardiovascular diseases (CVDs) is anticipated to fuel the expansion of the omega-3 prescription drug market. Elevated blood triglyceride levels, which are a fatty-like substance, are associated with an increased likelihood of cardiovascular disorders, and omega-3 supplements are beneficial in controlling and reducing these levels. As an illustration, in August 2025, the National Institutes of Health, a US-based government agency, forecasted that from 2025 to 2050, cardiovascular prevalence is expected to climb by 90%, mortality by 73%, and DALYs by 55%, with fatalities growing from 20.5 million to 35.6 million. Consequently, the escalating number of cardiovascular disease cases propels the growth of the omega-3 prescription drug market.

How Is The Omega 3 Prescription Drugs Market Structured Across Different Segments?

The omega 3 prescription drugs market covered in this report is segmented –

1) By Drug Type: Vascepa, Lovaza, Other Type

2) By Application Type: Hypertriglyceridemia, Other Application Type

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Vascepa: Pure EPA (Eicosapentaenoic Acid) Formulation, Indications For Cardiovascular Risk Reduction

2) By Lovaza: Combination Of EPA And DHA (Docosahexaenoic Acid), Indications For Hypertriglyceridemia Management

3) By Other Types: Epanova (Omega-3 Carboxylic Acids), Omega-3 Formulations In Clinical Trials, Other Prescription Omega-3 Products

Which Trends Are Shaping The Future Of The Omega 3 Prescription Drugs Market?

Leading firms within the omega-3 prescription drug market are prioritizing the introduction of new products, such as capsules, which are designed to reduce the amount of triglycerides the body produces. Capsules are dosage forms for pharmaceuticals or dietary supplements, typically featuring a shell made of gelatin or similar material, encapsulating a specific quantity of medication, nutrients, or other active components for convenient and easy ingestion. For instance, in March 2023, Hikma Pharmaceuticals, an England-based multinational pharmaceutical company specializing in generic and in-licensed pharmaceutical products, launched Icosapent Ethyl Capsules, 0.5g, in the US. This product is indicated for lowering triglyceride levels in adults diagnosed with severe hypertriglyceridemia and contains eicosatetraenoic acid (EPA), which is well-known for its triglyceride-reducing properties. This launch significantly innovates the market by providing a treatment for severe hypertriglyceridemia, addressing the growing demand for pharmaceutical-grade omega-3 products, and aligning with the market’s focus on effective therapies for conditions like high triglyceride levels.

Which Major Players Dominate The Omega 3 Prescription Drugs Market?

Major companies operating in the omega 3 prescription drugs market are Pfizer Inc., Sanofi S.A., Amarin Corporation plc, GlaxoSmithKline plc, AstraZeneca plc, Merck & Co. Inc., Novartis AG, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, BASF SE, DSM Nutritional Products, AbbVie Inc., Eli Lilly and Company, Bayer AG, Shire Pharmaceuticals, Mylan NV, Teva Pharmaceutical Industries Ltd., Horizon Therapeutics, Kyowa Kirin Co. Ltd., Sumitomo Pharma Co. Ltd.

Read the full omega 3 prescription drugs market report here:

https://www.thebusinessresearchcompany.com/report/omega-3-prescription-drugs-global-market-report

What Are The Top-Performing Regions Within The Omega 3 Prescription Drugs Market?

North America was the largest region in the omega 3 prescription drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omega 3 prescription drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Omega 3 Prescription Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8091&type=smp

Browse Through More Reports Similar to the Global Omega 3 Prescription Drugs Market 2026, By The Business Research Company

Omega 3 Prescription Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/omega-3-prescription-drugs-global-market-report

Omega 3 Market Report 2026

https://www.thebusinessresearchcompany.com/report/omega-3-global-market-report

Osteoporosis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795